Summary
Electrochemotherapy is an anti-tumour treatment that utilizes locally delivered electric pulses to increase cytotoxicity of chemotherapeutic drugs. The aim of our study was to determine whether anti-tumour effectiveness of electrochemotherapy with cisplatin is a consequence of increased plasma membrane permeability caused by electroporation that enables cisplatin binding to DNA. For this purpose, anti-tumour effectiveness of electrochemotherapy was evaluated on SA-1 tumours treated with electric pulses 3 min after intravenous injection of cisplatin (4 mg kg–1). Anti-tumour effectiveness was correlated with platinum accumulation in tumours and the amount of platinum bound to DNA, as determined by atomic absorption spectrometry. In tumours treated with electrochemotherapy, cell kill was increased by a factor of 20 compared with treatment with cisplatin only, as determined from tumour growth curves. The amount of platinum bound to DNA and platinum content in the tumours treated by electrochemotherapy was approximately two times higher than in cisplatin-treated tumours. Based on our results, we conclude that in vivo application of electric pulses potentiates anti-tumour effectiveness of cisplatin by electroporation that consequently results in cisplatin increased delivery into the cells. In addition, besides electroporation, immune system and tumour blood flow changes could be involved in the observed anti-tumour effectiveness of electrochemotherapy.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Belehradek, J. Jr, Orlowski, S., Ramirez, L. H., Pron, G., Poddevin, B. & Mir, L. M. (1994). Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta 1190: 155–163.
Cemaz̆ar, M., Miklavc̆ic̆, D., Vodovnik, L., Jarm, T., Rudolf, Z., S̆tabuc, B., Cufer, T. & Sers̆a, G. (1995). Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumors in mice. Radiol Oncol 29: 121–127.
Chu, G. (1994). Cellular responses to cisplatin. J Biol Chem 14: 787–790.
Corbett, T. H. & Valeriote, F. A. (1987). Rodent models in experimental chemotherapy. In Rodent Tumour Models in Experimental Cancer Therapy. Kallman RF (ed), pp. 233–247, Pergamon Press: New York
Gately, D. P. & Howell, S. B. (1993). Cellular accumulation of the anticancer agent cisplatin: A review. Br J Cancer 67: 1171–1176.
Heller, R., Jaroszeski, M., Leo-Messina, J., Perrot, R., Van Voorhis, N., Reintgen, D. & Gilbert, R. (1995). Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectroch Bioener 36: 83–87.
Jekunen, A. P., Shalinsky, D. R., Hom, D. K., Albright, K. D., Health, D. & Howell, S. B. (1993). Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochem Pharmacol 45: 2079–2085.
Marveti, G., Andrews, P. A., Piccinini, G., Ghiaroni, S., Barbieri, D. & Moruzzi, M. S. (1997). Modulation of cis-diamminedichloroplatinum (II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells. Eur J Cancer 33: 669–675.
Melvik, J. E., Pettersen, E. O., Gordon, P. B. & Selgen, P. O. (1986). Increase in cis-dichlorodiammineplatinum (II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells. Eur J Cancer Clin Oncol 22: 1523–1530.
Milac̆ic̆, R., Cemaz̆ar, M. & Sers̆a, G. (1997). Determination of platinum in tumor tissues after cisplatin therapy by electrothermal atomic absorption spectrometry. J Pharm Biomed Anal 16: 343–348.
Miller, S. A., Dykes, D. D. & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215
Mir, L. M., Orlowski, S., Belehradek, J. Jr & Paoletti, C. (1991). Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 27: 68–72.
Mir, L. M., Orlowski, S., Belehradek, J. Jr, Teissie, J., Rols, M. P., Sers̆a, G., Miklavc̆ic̆, D., Gilbert, R. & Heller, R. (1995). Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectroch Bioener 38: 203–207.
Mir, L. M., Tounekti, O. & Orlowski, S. (1996). Bleomycin: revival of an old drug. Gen Pharmacol 27: 745–748.
Mir, L. M., Glass, L. F., Sers̆ă, G., Teissie, J., Domenge, C., Miklavc̆ic̆, D., Jaroszeski, M. J., Orlowski, S., Reintgen, D. S., Rudolf, Z., Belehradek, M., Gilbert, R., Rols, M. P., Belehradek, J. Jr, Bachaud, J. M., DeConti, R., S̆tabuc, B., Cemaz̆ar, M., Coninx, P. & Heller, R. (1998). Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy. Br J Cancer 77: 2336–2342.
Okino, M. & Mohri, H. (1987). Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res 78: 1319–1321.
Orlowski, S. & Mir, L. M. (1993). Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1154: 51–63.
Poddevin, B., Orlowski, S., Belehradek Jr, J. & Mir, L. M. (1991). Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 42: S67–S75.
Sers̆a, G., Cemaz̆ar, M., Miklavc̆ic̆, D. & Mir, L. M. (1994). Electrochemotherapy: variable anti-tumor effect on different tumor models. Bioelectroch Bioener 35: 23–27.
Sers̆a, G., Cemaz̆ar, M. & Miklavc̆ic̆, D. (1995). Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res 55: 3450–3455.
Sers̆a, G., Miklavc̆ic̆, D., Cemaz̆ar, M., Belehradek, J. Jr, Jarm, T. & Mir, L. M. (1997). Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompetent and immunodeficient mice. Bioelectroch Bioener 43: 279–283.
Sers̆a, G., S̆tabuc, B., Cemaz̆ar, M., Janc̆ar, B., Miklavc̆ic̆, D. & Rudolf, Z. (1998a). Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients. Eur J Cancer 34: 1213–1218.
Sers̆a, G., Beravs, K., Cemaz̆ar, M., Miklavc̆ic̆, D. & Dems̆ar, F. (1998b). Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses. Electro Magnetobiol 17: 297–304.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Cemaz̆ar, M., Miklavc̆ic̆, D., S̆c̆anc̆ar, J. et al. Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 79, 1386–1391 (1999). https://doi.org/10.1038/sj.bjc.6690222
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690222
Keywords
This article is cited by
-
The application of point source electroporation and chemotherapy for the treatment of glioma: a randomized controlled rat study
Scientific Reports (2020)
-
Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model
Radiation and Environmental Biophysics (2019)